Investing Profile

Edward Van Wezel

InvestorVC
Founder and Managing Partner at BGV (BioGeneration Ventures)
Photo of Edward Van Wezel, Managing Partner at BGV (BioGeneration Ventures)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
cb
$100K - $1M
$500K
8
€250M
CompanyStageDateRound SizeTotal Raised
Azafaros
Series BMay 2025$150M
Series AFeb 2020$27M
SeedJul 2018
$180M
Co-investors: Sander Slootweg (Forbion)
Citryll
Series BDec 2024$90M
Series BJul 2020$21M
$110M
Co-investors: Isabelle de Cremoux (Seventure Partners), Florian Müllershausen (Novartis Venture Fund), Geert-Jan Mulder (Forbion)
Confo Therapeutics
Series BJul 2024$65M
Series AMay 2019$34M
$99M
Noviogendix Holding
Series UnknownJan 2007
Managing Director HotmailPresent
Founding investor and member of the supervisory board Acerta Pharma B.V. (A member of the AstraZeneca Group)Present
Board Director Scenic BiotechPresent
Board Director / Board Observer AZAFAROS B.V.Present
Board Director Confo TherapeuticsPresent
Director HotmailPresent
Board Director Kivu BiosciencePresent
Board Director Libertatis Ergo Holding B.V.Present
Board Observer Epsilogen LtdPresent
Founder and Managing Partner BGV (BioGeneration Ventures)Present